Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years and = 3 and/or positive PSMA PET/CT); 5. Clinical stage T1-3AN0M0; 6. Signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. History of urinary tract infection or acute prostatitis within 3 months; 2. Previous prostate biopsy or other prostate surgery, such as transurethral resection of the prostate; 3. Previous endocrine therapy; 4. Previously received pelvic radiotherapy; 5. Mental illness is unable to understand surgical procedures and sign informed consent; 6. Severe cardiopulmonary and other related diseases, unable to tolerate radical prostatectomy; 7. Other researchers think it is not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical relapse-free survival at 1 year after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| hospitalization expenses;length of stay;Surgeon's rating of the degree of intraoperative inflammatory adhesion of the prostatic apex;Patient satisfaction;Complications according to Clavien-Dindo classification;The operation time;Estimated blood loss;Positive rate of surgical margin in radical prostatectomy;The accuracy of intraoperative rapid freezing in pathological diagnosis;The coincidence rate of Gleason score between intraoperative rapid freezing pathology and postoperative radical pathology;Risk factors affecting the accuracy of frozen pathology in targeted biopsy;Incidence of urinary incontinence 1 year after operation; | — |
Countries
China
Contacts
Beijing Hospital